Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin

Lasers in Surgery and Medicine

Volumn 39, Issue 3, 2007, Pages 203-209

  Zane, Cristina ^a   Capezzera, Rossana ^a   Sala, Raffaella ^a   Venturini, Marina ^a   Calzavara Pinton, Piergiacomo ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Azienda Spedali Civili ^*  (Italy)

Author keywords

Actinic keratosis; Echographic evaluation; Methylaminolevulinate; Photoaging; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; LEVULAN KERASTIC; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG EFFICACY; DRUG TOLERABILITY; ECHOGRAPHY; FACE DISORDER; FEMALE; HUMAN; HYPERPIGMENTATION; MALE; OUTCOME ASSESSMENT; PHOTOAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; SCORING SYSTEM; SKIN DEFECT; SKIN MANIFESTATION; SKINFOLD THICKNESS; TELANGIECTASIA; TREATMENT OUTCOME;

AGED; AMINOLEVULINIC ACID; FEMALE; HUMANS; HYPERPIGMENTATION; KERATOSIS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN; SKIN AGING; SUNLIGHT;

EID: 34247263843     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20470     Document Type: Article

References (32)

1. Ormrod D, Jarvis B. Topical aminolevulinic acid HCL photodynamic therapy. Am J Clin Dermatol 2000;1:133-139.
2. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle T, Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002;47:258-262.
3. Price DD, McGrath PA, Raffi A, Buckingham B. The validation of visual analog scale as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
4. Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005;141:1247-1252.
5. Pellacani G, Seidenari S. Variations in facial skin thickness and echogenicity with site and age. Acta Derm Venereol (Stockh) 1999;79:l-4.
6. Goldman MP, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: Real world experience. J Lasers Med Surg 2002;14:S24.
7. Gold MH. Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy. J Lasers Med Surg 2003;15:S47.
8. Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: Where we have been and where we are going. Dermatol Surg 2004;30:1077-1084.
9. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004;140:33-34.
10. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004;3:S38-S39.
11. Key DJ. Aminolevulinic acid pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmetic Dermatol 2005;18:31-36.
12. Hall JA, Keller PJ, Keller GS. Dose response of combination photorejuvenation using intense pulsed light- activated photodynamic therapy and radiofrequency energy. Arch Facial Plast Surg 2004;6:374-378.
13. Nelson JS, Milner TE, Anvari B, Tanenbaum BS, Kimel S, Svaasand LO, Jacques SL. Dynamic epidermal cooling during pulsed laser treatment of port-wine stain. A new methodology with preliminary clinical evaluation. Arch Dermatol 1995;131:695-700.
14. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol Surg 2002;28:742-744.
15. Alexiades-Armenakes MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003;139:1313-1320.
16. Lowe NJ, Lowe P. Pilot study to determine the efficacy of ALA-PDT photo-rejuvenation for the treatment of facial ageing. J Cosmet Laser Ther 2005;7:159-162.
17. Gaullier JM, Berg K, Peng Q, Anholt H, Selbo PK, Ma LW, Moan J. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997;57:1481-1486.
18. Peng Q, Moan J, Warloe T, Iani V, Steen HB, Bjorseth A, Nesland JM. Build up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B 1996;34:95-96.
19. Russell BA, Kellett N, Reilly LR. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther 2005;7:196-200.
20. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003;139:1173-1177.
21. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester.. Photochem Photobiol 1998;68:218-221.
22. Oseroff A. PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 2006;126:542-544.
23. Angell-Petersen E, Sørensen R, Warloe T, Soler AM, Moan J, Peng Q, Giercksky KE. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl-5-aminolevulinate. J Invest Dermatol 2006;126:265-271.
24. Zakhary K, Ellis DA. Applications of aminolevulinic acid-based photodynamic therapy in cosmetic facial plastic practices. Facial Plast Surg 2005;21:110-116.
25. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004;151:776-783.
26. Schacht V, Szeimies RM, Abels C. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application. Photochem Photobiol Sci 2006;5:452-458.
27. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 2004;3 (6 Suppl):S6-S9.
28. Perrett CM, McGregor J, Barlow RJ, Karran P, Proby C, Harwood CA. Topical photodynamic therapy with methyl aminolevulinate to treat sebaceous hyperplasia in an organ transplant recipient. Arch Dermatol 2006;142:781-782.
29. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997;66:493-496.
30. Sharfaei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res 2002;294:237-242.
31. Wulf HC, Pavel S, Stender I, Bakker- Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006;86:25-28.
32. de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006;126:569-574.